new paradigms/therapies in relapsed/refractory myeloma: small molecules & monoclonal antibodies
Published 7 years ago • 97 plays • Length 19:06Download video MP4
Download video MP3
Similar videos
-
25:18
new paradigms/therapies in relapsed/refractory myeloma
-
21:07
monoclonal antibodies for myeloma: a new wave for the future
-
44:23
monoclonal antibodies for multiple myeloma
-
28:40
the future of antibody therapies and drug conjugates in multiple myeloma
-
22:55
future therapies in multiple myeloma
-
3:25
monoclonal antibodies in relapsed-refractory myeloma
-
40:06
multiple myeloma: a pathway to better outcomes
-
1:59
optimal treatment sequencing for relapsed/refractory myeloma
-
19:02
multiple myeloma: newest treatments for relapsed/refractory mm | for patients & caregivers
-
34:13
which is the most important target for monoclonal antibodies in myeloma therapy?
-
49:25
therapy of relapsed multiple myeloma - an update
-
3:25
what are the newest drugs and treatments for relapsed and refractory myeloma?
-
20:07
emerging small molecule therapies with promise in myeloma
-
9:41
redirectt-1 study: dual targeting of bcma and gprc5d in rrmm pts with teclistamab and talquetamab
-
21:41
the future in multiple myeloma: bite immunotherapy, car-t, and immune checkpoint inhibitors
-
14:01
imid plus monoclonal antibody?
-
1:26
emerging monoclonal antibodies for the treatment of multiple myeloma
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
5:05
bispecific antibody therapy in relapsed/refractory myeloma | meera mohan, md, ms, facp | asco 2023